HHS Awards $27.8M Contract for 9/11 Survivor Clinical Center of Excellence to NYC Health and Hospitals
Contract Overview
Contract Amount: $27,793,362 ($27.8M)
Contractor: NEW York City Health and Hospitals Corporation
Awarding Agency: Department of Health and Human Services
Start Date: 2025-09-26
End Date: 2026-09-28
Contract Duration: 367 days
Daily Burn Rate: $75.7K/day
Competition Type: FULL AND OPEN COMPETITION
Number of Offers Received: 1
Pricing Type: COST NO FEE
Sector: Healthcare
Official Description: SERVICES TO PROVIDE A 9/11 SURVIVOR CLINICAL CENTER OF EXCELLENCE
Place of Performance
Location: NEW YORK, NEW YORK County, NEW YORK, 10004
State: New York Government Spending
Plain-Language Summary
Department of Health and Human Services obligated $27.8 million to NEW YORK CITY HEALTH AND HOSPITALS CORPORATION for work described as: SERVICES TO PROVIDE A 9/11 SURVIVOR CLINICAL CENTER OF EXCELLENCE Key points: 1. Contract awarded to a single entity for specialized clinical services. 2. Focus on long-term health needs of 9/11 survivors. 3. Potential for high impact on a specific patient population. 4. Requires robust monitoring to ensure quality of care and cost-effectiveness.
Value Assessment
Rating: good
The contract value of $27.8 million over approximately one year appears reasonable given the specialized nature of the services. Benchmarking is difficult without specific service details, but the 'Cost No Fee' (Cost-Reimbursement) contract type suggests costs will be monitored closely.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
The contract was awarded under full and open competition, indicating multiple vendors had the opportunity to bid. This method generally promotes competitive pricing and ensures the government receives the best value.
Taxpayer Impact: Taxpayer funds are being used to provide essential, long-term healthcare for a deserving population, representing a significant investment in public health.
Public Impact
Provides critical, specialized medical care for 9/11 survivors. Establishes a center of excellence for ongoing research and treatment. Addresses the long-term health consequences of a national tragedy.
Waste & Efficiency Indicators
Waste Risk Score: 75 / 10
Warning Flags
- Ensuring long-term efficacy of treatment for complex conditions.
- Monitoring cost controls within a Cost-Reimbursement contract.
Positive Signals
- Addresses a critical public health need for a specific population.
- Leverages existing healthcare infrastructure in New York City.
- Awarded through full and open competition.
Sector Analysis
This contract falls within the healthcare sector, specifically focusing on outpatient care centers. The spending benchmark for similar specialized clinical centers can vary widely based on scope and patient volume, but this award appears aligned with significant public health initiatives.
Small Business Impact
There is no indication in the provided data that small businesses were involved in this contract award. Future opportunities for subcontracting with small businesses should be explored to ensure broader economic participation.
Oversight & Accountability
The Centers for Disease Control and Prevention (CDC) is responsible for overseeing this contract. Robust oversight will be crucial to ensure the quality of care, adherence to clinical protocols, and effective use of taxpayer funds.
Related Government Programs
- All Other Outpatient Care Centers
- Department of Health and Human Services Contracting
- Centers for Disease Control and Prevention Programs
Risk Flags
- Potential for long-term cost escalation if patient conditions worsen.
- Ensuring consistent quality of care across all services provided.
- Dependency on a single provider for critical, specialized care.
- Measuring the true long-term health impact and cost-effectiveness.
Tags
all-other-outpatient-care-centers, department-of-health-and-human-services, ny, definitive-contract, 10m-plus
Frequently Asked Questions
What is this federal contract paying for?
Department of Health and Human Services awarded $27.8 million to NEW YORK CITY HEALTH AND HOSPITALS CORPORATION. SERVICES TO PROVIDE A 9/11 SURVIVOR CLINICAL CENTER OF EXCELLENCE
Who is the contractor on this award?
The obligated recipient is NEW YORK CITY HEALTH AND HOSPITALS CORPORATION.
Which agency awarded this contract?
Awarding agency: Department of Health and Human Services (Centers for Disease Control and Prevention).
What is the total obligated amount?
The obligated amount is $27.8 million.
What is the period of performance?
Start: 2025-09-26. End: 2026-09-28.
What specific clinical services will the Center of Excellence provide, and how do these align with the long-term health needs of 9/11 survivors?
The Center of Excellence is expected to offer comprehensive clinical services tailored to the chronic health conditions associated with 9/11 exposure, such as respiratory illnesses, cancers, and mental health issues. This includes diagnosis, treatment, ongoing monitoring, and potentially research into these conditions, ensuring survivors receive specialized, long-term care.
How will the CDC ensure cost-effectiveness and prevent potential cost overruns within this 'Cost No Fee' contract?
The CDC will implement rigorous financial oversight, requiring detailed cost reporting and justification from the contractor. Regular audits, performance reviews tied to cost metrics, and clear deliverables will be essential. Establishing clear benchmarks for service delivery and patient outcomes will also help manage costs effectively.
What mechanisms are in place to measure the effectiveness of the clinical center and its impact on the health outcomes of 9/11 survivors?
Effectiveness will be measured through key performance indicators (KPIs) focused on patient health outcomes, such as disease progression, quality of life improvements, and patient satisfaction. Data collection on treatment efficacy, adherence to best practices, and long-term health trends among the survivor population will be critical for evaluation.
Industry Classification
NAICS: Health Care and Social Assistance › Outpatient Care Centers › All Other Outpatient Care Centers
Product/Service Code: MEDICAL SERVICES › GENERAL HEALTH CARE SERVICES
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION
Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE
Solicitation ID: 75D301-25-R-73371
Offers Received: 1
Pricing Type: COST NO FEE (S)
Evaluated Preference: NONE
Contractor Details
Address: 50 WATER ST FL 3, NEW YORK, NY, 10004
Business Categories: Category Business, Government, Hospital, U.S. Local Government, U.S. National Government, Not Designated a Small Business, Special Designations
Financial Breakdown
Contract Ceiling: $165,914,538
Exercised Options: $27,793,362
Current Obligation: $27,793,362
Contract Characteristics
Commercial Item: COMMERCIAL PRODUCTS/SERVICES PROCEDURES NOT USED
Cost or Pricing Data: YES
Timeline
Start Date: 2025-09-26
Current End Date: 2026-09-28
Potential End Date: 2030-09-28 00:00:00
Last Modified: 2025-12-08
More Contracts from NEW York City Health and Hospitals Corporation
- World Trade Center Health Program Clinical Center of Excellence Services — $89.9M (Department of Health and Human Services)
- Wtchp Clinical Center of Excellence — $78.3M (Department of Health and Human Services)
- World Trade Center Clinical Centers of Excellence — $34.5M (Department of Health and Human Services)
- Data Center NYC HH — $22.8M (Department of Health and Human Services)
View all NEW York City Health and Hospitals Corporation federal contracts →
Other Department of Health and Human Services Contracts
- Contact Center Operations (CCO) — $5.5B (Maximus Federal Services, Inc.)
- TAS::75 0849::TAS Oper of Govt R&D Goco Facilities — $4.8B (Leidos Biomedical Research Inc)
- THE Purpose of This Contract IS to Provide the Full Complement of Services Necessary to Care for UC in ORR Custody Including Facilities Set-Up, Maintenance, and Support Internal and Perimeter (IF Applicable) Security, Direct Care and Supervision Inc — $3.5B (Rapid Deployment Inc)
- Contact Center Operations — $2.6B (Maximus Federal Services, Inc.)
- Federal Contract — $2.4B (Leidos Biomedical Research Inc)
View all Department of Health and Human Services contracts →